- A serotonin–norepinephrine–dopamine
releasing agent (
SNDRA), also
known as a
triple releasing agent (TRA), is a type of drug
which induces the release...
-
releasing agent (
SNDRA), and weak RIMA
Etryptamine [α-Ethyltryptamine (αET)] (Monase) – non-selective
serotonin receptor agonist,
SNDRA, and weak RIMA Indeloxazine...
- pharmacology, MDA is a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). In most countries, the drug is a
controlled substance and its possession...
- 5-chloro-αMT, BK-NM-AMT) Serotonin–norepinephrine–dopamine
releasing agent (
SNDRA) (e.g., MDMA, mephedrone) The
differences in
selectivity of MRAs is the...
-
derivative which acts as a serotonin-norepinephrine-dopamine
releasing agent (
SNDRA) and
produces stimulant effects.
Another related compound is para-bromomethamphetamine...
-
specifically a well-balanced serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). To a
lesser extent, MDMA also acts as a serotonin–norepinephrine–dopamine...
- respectively, are
potent serotonin–norepinephrine–dopamine
releasing agents (
SNDRAs). They have been
encountered as
cathinone designer and
recreational drugs...
-
appears to act as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA),
although it is
significantly less
potent than MDMA.
Montgomery T, Buon...
- family. It acts as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). The drug is the β-deketo
analogue of
mephedrone (4-methylmethcathinone;...
- 4-CMC
mainly acts as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA), and
partially as a serotonin-norepinephrine-dopamine
reuptake inhibitor...
